Postmarketing Surveillance Study of Prolia (Denosumab) in South Korea

16/03/2017
22/01/2021
EU PAS number:
EUPAS17915
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

01 20 01 Protocol Ver 1 0 2016-08-29 redacted

English (437.96 KB - PDF) View document
Study results
Study results

Prolia_Abstract_Final_18Dec2020

English (100.15 KB - PDF) View document
Study report
Other information